The DTaP vaccine protects children against three serious bacterial infections: diphtheria, tetanus, and pertussis (whooping cough). It’s given as a five-dose series starting at 2 months of age and is one of the core childhood vaccinations recommended by the CDC. The “aP” in DTaP stands for “acellular pertussis,” meaning it uses purified pieces of the pertussis bacteria rather than whole killed cells, which reduces side effects compared to older versions of the vaccine.
The Three Diseases DTaP Prevents
Each of the three infections DTaP targets is caused by a different type of bacteria, and each poses distinct risks to young children.
Diphtheria is highly contagious and causes a thick gray coating to form in the nose and throat. Children develop a sore throat, mild fever, weakness, and swollen neck glands. The bacteria release toxins that can damage the heart, kidneys, and nervous system. Before widespread vaccination, diphtheria killed thousands of children each year in the United States.
Tetanus enters the body through cuts, scrapes, or puncture wounds. It causes painful muscle stiffness and cramping throughout the body, starting with the jaw (which is why it’s called “lockjaw”). Children with tetanus can develop trouble swallowing, seizures, changes in heart rate and blood pressure, and fever. Unlike diphtheria and pertussis, tetanus doesn’t spread from person to person. The bacteria live in soil, dust, and manure.
Pertussis, or whooping cough, starts out looking like a mild cold with a runny nose and low-grade fever. Within a week or two, it progresses into violent coughing fits so intense that children vomit, struggle to breathe, and make a high-pitched “whoop” sound when they finally inhale. Babies are especially vulnerable because pertussis can cause life-threatening pauses in breathing. Between coughing fits, children often appear fine, which can make the illness deceptive in its early stages.
The Five-Dose Schedule
DTaP is given to children younger than 7 years old across five doses at specific ages:
- 2 months
- 4 months
- 6 months
- 15 to 18 months
- 4 to 6 years
The first three doses, spaced two months apart, build the foundation of immunity. The fourth dose at 15 to 18 months serves as a booster after a longer gap, and the fifth dose before kindergarten reinforces protection heading into school. Children who miss a dose don’t need to restart the series. Your pediatrician can adjust the timing to get back on track.
How Well It Works
When children complete all five doses on schedule, DTaP fully protects 98% of them against pertussis within the first year after the final dose. That number drops to about 71% five years later. Protection against diphtheria and tetanus holds up longer because those components of the vaccine are highly stable toxoids (inactivated bacterial toxins that train the immune system without causing disease).
The pertussis component is where immunity fades most noticeably. A large study published in the Canadian Medical Association Journal tracked how protection changed over time: effectiveness sat around 80 to 84% in the first three years after vaccination, fell to 62% between four and seven years out, and dropped to roughly 41% after eight or more years. For each year that passed after the last acellular pertussis dose, the odds of testing positive for pertussis increased by about 27%. This waning immunity is the main reason booster shots are needed as children grow older.
DTaP vs. Tdap
DTaP and Tdap protect against the same three diseases but are formulated for different age groups. DTaP uses higher doses of the diphtheria and pertussis components and is designed for children under 7. Tdap contains lower doses of those same components and is given to older children and adults. The lowercase letters in “Tdap” signal the reduced amounts.
The CDC recommends a single Tdap booster at age 11 to 12, which helps restore the pertussis protection that has faded since the fifth DTaP dose. Pregnant individuals are also advised to get Tdap during each pregnancy to pass protective antibodies to the newborn before the baby is old enough to start their own DTaP series.
Common Side Effects
Most children experience some reaction after a DTaP shot, and the vast majority of these are mild and short-lived. In clinical studies, about 87% of vaccinated children had at least one side effect. The most common was fever, occurring in roughly two-thirds of children. Other reactions included general fussiness or feeling unwell (38%), loss of appetite (25%), and sleep disruption (20%). Vomiting and prolonged crying each occurred in fewer than 8% of children.
At the injection site, about 42% of children experienced pain or tenderness, 28% had redness, and 20% developed a small firm lump under the skin. These local reactions typically resolve within a day or two. Side effects tend to be more noticeable after the fourth and fifth doses than after the earlier ones.
When DTaP Should Be Delayed or Skipped
There is only one condition specific to the pertussis component that rules out future DTaP doses: if a child develops encephalopathy (a serious brain disorder) within seven days of receiving the vaccine, and no other cause is identified. This is extremely rare. In that situation, a child can still receive the DT vaccine, which covers diphtheria and tetanus without the pertussis component.
A child with a moderate or severe illness is typically asked to wait until they recover before getting vaccinated, but a mild cold or low-grade fever isn’t a reason to postpone. It’s also worth noting that a family history of vaccine reactions is not a reason to skip DTaP. Each child’s immune response is individual, and a sibling’s reaction doesn’t predict what will happen for another child.
Why Timing Matters for Infants
Pertussis is most dangerous in babies under 12 months old, which is exactly the window before the DTaP series can build strong protection. The first dose at 2 months begins priming the immune system, but robust immunity doesn’t develop until after the third dose at 6 months. That gap is why “cocooning” matters: making sure everyone who spends time around a young baby, including parents, grandparents, and caregivers, is up to date on their own Tdap booster. Keeping doses on schedule gives the baby the earliest possible protection during the most vulnerable period.